Poor prognosis of pulmonary sarcomatoid carcinoma with KRAS mutation and ALK fusion

Pulmonary sarcomatoid carcinoma (PSC) is a rare subtype of poorly differentiated non-small-cell lung cancer (NSCLC), and no effective treatment is available in clinical practice currently. In the present report, a 61-year-old male patient was hospitalized due to cough, dyspnea, and right chest pain....

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fangmin, Gu, Qihua, Hu, Chengping, Cai, Xiaoling, Lei, Shuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501700/
https://www.ncbi.nlm.nih.gov/pubmed/31118683
http://dx.doi.org/10.2147/OTT.S196751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501700/
https://www.ncbi.nlm.nih.gov/pubmed/31118683
http://dx.doi.org/10.2147/OTT.S196751

Ejemplares similares